Patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) usually face lifelong treatments to keep the disease in check. This …
Sanofi Faces French Scrutiny and Investigation Over Taxotere Deaths
A popular chemo drug from French manufacturer Sanofi is under fire in the European Union over unexpected patient deaths. Doctors …
Breast Cancer Chemotherapy: Common Drugs, Acronyms & Side Effects
Breast cancer chemotherapy jargon can get complicated. Most often doctors prescribe not just one drug, but a “chemo cocktail” combination …
Studies: Melatonin Slows Breast Cancer Progression, Eases Chemo Pain
We almost never get the chance to share good news about cancer. But thanks to several recent studies, it seems …
Chemo Permanent Hair Loss: What Some Taxotere Patients Can Expect
Most patients expect to lose some hair (if not all) during chemotherapy treatment. But reasonably, most people also believe it …
Hair Regrowth After Chemo: What to Expect, and When
Cancer takes a physical and emotional toll. The disease disrupts not only physical well-being, but also the patient’s life plans, …
Newest Taxane Drug, Tesetaxel, May Help Cancer Patients Skip Infusions
There’s a new oral taxane drug on the horizon that could be a game-changer for advanced gastric and breast cancer …
Tasigna Removed From Several 2018 Drug Formulary Lists
It’s no secret that drug manufacturers and distributors earn incredible profit margins on medication sales. Even when generic versions are …
Docetaxel Chemo Claims May Reach Settlements Before Upcoming Trials
Despite gaining the U.S. Food and Drug Administration’s approval in 1996, Taxotere (generic: docetaxel) has spent years embroiled in litigation. …
FDA Approves Actemra for Cytokine Release Syndrome
In August, the U.S. Food and Drug Administration (FDA) approved Actemra to treat CAR T cell-induced cytokine release syndrome (CRS). …